Bristol-Myers Squibb (BMY) Tops Q2 EPS by 15c, Updates FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
August 6, 2020 6:59 AM EDTReports Second Quarter Revenues of $10.1 Billion Posts GAAP Loss Per Share of $0.04 and Non-GAAP EPS of $1.63 Advances Pipeline with Positive Topline Results for Zeposia in Ulcerative Colitis; Approvals for Opdivo plus Yervoy in Lung Cancer Updates 2020 GAAP EPS Guidance Range from $0.37-$0.57 to ($0.06)-$0.09 and Non-GAAP EPS Guidance Range from $6.00-$6.20 to $6.10-$6.25
NEW YORK--(BUSINESS... More
